Market Brief

The articles are produced in Chinese only.

Author

區良鍵先生(George Au)
業務副董事

工商管理(財務系)畢業, 有十多年投資經驗, 經歷過股災及大大小小的升/跌市. 善於配合基礎因素及技術分析, 整合不同投資工具, 在不同市況下作出相應投資決定. 熟悉本地投資市場, 尤精於股票期權、指數期權及期貨投資.
Phone:
3925 9237

Title: 最佳聖誕禮物

Tuesday, December 15, 2020 Views9045
經過充滿變數, 波動的一年, 2020年終於來到年底.
 
隨多國的疫苗測試都有正面結果, 市場其中最大的一個擔憂亦得以舒緩.
12月傳統上是交投淡靜的月份, 加上疫苗等不同影響市況的因素大致塵埃落定, 市況變化不大
 
這情況最適合 Short Option 的投資者.
香港股市走勢落後外圍, 不論新/舊經濟, 當中優質的股票在目前水平都有不錯支持.
加上市況淡靜, Short Put 收取期權金, 賺取潛在溢價(e.g. 時間值, 引伸波幅) 可能是不錯的選擇.
 
另外, 美國目前的水平有些虛高. (10/Dec 道瓊斯指數12月期貨約 30,000點)
疫苗相關的好消息已出得七七八八, 總統位置又有司法挑戰,
所謂刺激經濟方案, 選前至選後仍只是討論中, 民主黨最初的目標是 ~2萬億的方案, 目前討論的只是 <1萬億, 還要未有結論.
 
這情況下, 道指升至 30,300點已差不多, 年底前再升空間不大.
沽3月道指期貨 (Short Dows Futures), 如道指出現調整時可能有理想利潤
 

註: 期貨及期權價格可升可跌, 投資可賺可蝕.
期貨及期權買賣有槓桿效應, 可放大潛在利潤及損失. 潛在最大損失可以無限.
 
以上純屬個人意見,不構成任何買賣邀請。本人區良鍵為證監會持牌人,本人及/或其有聯繫者會隨時就不同情況買賣上述分析的相關資產.


 

This report is produced and is being distributed in Hong Kong by Phillip Securities Group with the Securities and Futures Commission (“SFC”) licence under Phillip Securities (HK) LTD and/ or Phillip Commodities (HK) LTD (“Phillip”). Information contained herein is based on sources that Phillip believed to be accurate. Phillip does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The information is for informative purposes only and is not intended to or create/induce the creation of any binding legal relations. The information provided do not constitute investment advice, solicitation, purchase or sell any investment product(s). Investments are subject to investment risks including possible loss of the principal amount invested. You should refer to your Financial Advisor for investment advice based on your investment experience, financial situation, any of your particular needs and risk preference. For details of different product's risks, please visit the Risk Disclosures Statement on http://www.phillip.com.hk. Phillip (or employees) may have positions/ interests in relevant investment products. Phillip (or one of its affiliates) may from time to time provide services for, or solicit services or other business from, any company mentioned in this report. The above information is owned by Phillip and protected by copyright and intellectual property Laws. It may not be reproduced, distributed or published for any purpose without prior written consent from Phillip.
Top of Page
Contact Us
Please contact your account executive or call us now.
Research Department
Tel : (852) 2277 6846
Fax : (852) 2277 6565
Email : businessenquiry@phillip.com.hk

Enquiry & Support
Branches
The Complaint Procedures
About Us
Phillip Securities Group
Join Us
Phillip Network
Phillip Post
Phillip Channel
Latest Promotion
E-Check
Login
Investor Notes
Free Subscribe
Contact Us